Interstitial Cystitis / Painful Bladder

Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: Does ESSIC criteria change the response rate? - Abstract

AIMS: The European Society for the Study of Interstitial Cystitis (ESSIC) recommended that interstitial cystitis (IC) should be replaced by bladder pain syndrome (BPS), which focused more attention on the painful or discomfort feeling related to bladder and weakened the importance of cystoscopy in diagnosis process.

Adaptation of the O'Leary-Sant and the PUF for the diagnosis of interstitial cystitis for the Brazilian culture - Abstract

The aim of this study was to translate and adapt the instruments known as The O'Leary-Sant and PUF to the Brazilian culture used in the diagnosis of interstitial cystitis.

Interstitial cystitis: Another IgG4-related inflammatory disease? - Abstract

Interstitial cystitis (IC) is a disease of undetermined etiology and pathogenesis.

Effectiveness of acupuncture and moxibustion therapy for the treatment of refractory interstitial cystitis - Abstract

The efficacy of acupuncture and moxibustion treatment was examined on eight female patients with refractory interstitial cystitis (IC) who had been treated conservatively with hydrodistension, intravesical instillation of dimethyl sulfoxide, or oral medication.

Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C - Abstract

INTRODUCTION AND HYPOTHESIS: Bladder pain syndrome/interstitial cystitis (BPS/IC) is identified based on subjective symptoms which lead to heterogeneous patient populations.

Estrogen and progesterone receptors in patients with bladder pain syndrome - Abstract

OBJECTIVE: Analyze if bladder mucosa of patients with bladder pain syndrome (BPS) have more estrogen receptor (ER) and progesterone receptor (PR) than the normal population.

Quality of information on the internet related to bladder pain syndrome: A systematic review of the evidence - Abstract

INTRODUCTION AND HYPOTHESIS: Bladder pain syndrome (BPS) has an impact on quality of life and available treatments often only provide temporary symptomatic relief.

Improvement by the phytotherapeutic agent Eviprostat® of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide-induced cystitis, "Beyond the Abstract," by Shizuo Yamada, PhD

BERKELEY, CA (UroToday.com) - Interstitial cystitis (IC) is a chronic, abacterial, inflammatory disease of the bladder characterized by urinary frequency, urgency, and suprapubic pain associated with bladder filling and relieved by voiding.

Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C - Abstract

Objective: Bladder pain syndrome/interstitial cystitis (BPS/IC) is a chronic inflammatory disease and to date few treatments or tools for investigating the activity of the disease are available.

ESSIC criteria for the diagnosis of bladder pain syndrome / interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria - Abstract

OBJECTIVES: To apply the diagnostic criteria of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the criteria of the European Society for Study of Interstitial Cystitis (ESSIC) in our population with Bladder Pain Syndrome /interstitial cystitis (BPS/IC).

Log in

Interstitial Cystitis / Painful Bladder

More Articles...